Common use of All Notices Clause in Contracts

All Notices. All notices under this Agreement are deemed fully given when written, addressed, and sent as follows: All general notices to Forty Seven are mailed or emailed to: Xxxxxxxx XxxXxxxxx Forty Seven Inc. [*] With a copy to: Xxxx Xxxxxxx Xxxxxx Xxxxxxx Xxxxxxxx & Xxxxxx 000 Xxxx Xxxx Xxxx Xxxx Xxxx, XX 00000 xxxxxxxx@xxxx.xxx All financial invoices to Forty Seven (i.e., accounting contact) are e-mailed to: Xxxxxxxx XxxXxxxxx [*] All progress report invoices to Forty Seven (i.e., technical contact) are e-mailed to: Xxxxxxxx XxxXxxxxx [*] All general notices to Stanford are e-mailed or mailed to: Office of Technology Licensing 0000 Xx Xxxxxx Xxxx Xxxxxxxx 0, Xxxxx 000 Xxxx Xxxx, XX 00000-0000 xxxx@xxxxxxx.xxxxxxxx.xxx All payments to Stanford are mailed to: Stanford University Office of Technology Licensing Department #44439 X.X. Xxx 00000 Xxx Xxxxxxxxx, XX 00000-0000 All progress reports to Stanford are e-mailed or mailed to: Office of Technology Licensing 0000 Xx Xxxxxx Xxxx Xxxxxxxx 0, Xxxxx 000 Xxxx Xxxx, XX 00000-0000 xxxx@xxxxxxx.xxxxxxxx.xxx [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Any notice related to Section 7.4 or Section 7.5 (Stanford Purchase Rights) shall be copied concurrently to xxxxxxxxxx@xxxxxxxx.xxx Either party may change its address with written notice to the other party.

All Notices. All notices under this Agreement are deemed fully given when written, addressed, and sent as follows: All general notices to Forty Seven Alexo are mailed or emailed to: Xxxxxxxx XxxXxxxxx Forty Seven Alexo Therapeutics International c/o Alexo Therapeutics, Inc. [***] With *** Certain information in this agreement has been omitted and filed separately with the Securities and Exchange Commission. [***] indicates that text has been omitted and is the subject of a copy to: Xxxx Xxxxxxx Xxxxxx Xxxxxxx Xxxxxxxx & Xxxxxx 000 Xxxx Xxxx Xxxx Xxxx Xxxx, XX 00000 xxxxxxxx@xxxx.xxx confidential treatment request. All financial invoices to Forty Seven Alexo (i.e., accounting contact) are e-mailed to: Xxxxxxxx XxxXxxxxx Alexo Therapeutics International c/o Alexo Therapeutics, Inc. [***] All progress report invoices to Forty Seven Alexo (i.e., technical contact) are e-mailed to: Xxxxxxxx XxxXxxxxx Alexo Therapeutics International c/o Alexo Therapeutics, Inc. [***] All general notices to Stanford are e-mailed or mailed to: Office of Technology Licensing 0000 Xx Xxxxxx Xxxx Xxxxxxxx 0, Xxxxx 000 Xxxx Xxxx, XX 00000-0000 xxxx@xxxxxxx.xxxxxxxx.xxx All payments to Stanford are mailed to: Stanford University Office of Technology Licensing Department #44439 X.X. Xxx 00000 Xxx Xxxxxxxxx, XX 00000-0000 All progress reports to Stanford are e-mailed or mailed to: Office of Technology Licensing 0000 Xx Xxxxxx Xxxx Xxxxxxxx 0, Xxxxx 000 Xxxx Xxxx, XX 00000-0000 xxxx@xxxxxxx.xxxxxxxx.xxx [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Any notice related to Section 7.4 or Section 7.5 (Stanford Purchase Rights) shall be copied concurrently to xxxxxxxxxx@xxxxxxxx.xxx xxxx@xxXxxxx.xxxxxxxx.xxx Either party may change its address with written notice to the other party.

All Notices. All notices under this Agreement are deemed fully given when written, addressed, and sent as follows: All general notices to Forty Seven LogicBio are mailed or emailed to: Xxxxxxxx XxxXxxxxx Forty Seven LogicBio Therapeutics, Inc. [*] With a copy toAttention: Xxxx Xxxxxxx Xxxxxx Xxxxxxx Xxxxxxxx & Xxxxxx Chief Business Officer 000 Xxxx Xxxx Xxxx Xxxx XxxxXxxxxx, Xxxxxxxxx, XX 00000 xxxxxxxx@xxxx.xxx xxxxxxx@xxxxxxxxxxxxxxxxxxxx.xxx All financial invoices to Forty Seven LogicBio (i.e., accounting contact) are mailed or e-mailed to: Xxxxxxxx XxxXxxxxx [*] LogicBio Therapeutics, Inc. Attention: Chief Business Officer 000 Xxxx Xxxxxx, Xxxxxxxxx, XX 00000 xxxxxxx@xxxxxxxxxxxxxxxxxxxx.xxx All progress report invoices to Forty Seven LogicBio (i.e., technical contact) are mailed or e-mailed to: Xxxxxxxx XxxXxxxxx [*] LogicBio Therapeutics, Inc. Attention: Chief Business Officer 000 Xxxx Xxxxxx, Xxxxxxxxx, XX 00000 xxxxxxx@xxxxxxxxxxxxxxxxxxxx.xxx All general notices to Stanford are e-mailed or mailed to: Office of Technology Licensing 0000 Xx Xxxxxx Xxxx Xxxxxxxx 0, Xxxxx 000 Xxxx Xxxx, XX 00000-0000 xxxx@xxxxxxx.xxxxxxxx.xxx All payments to Stanford are mailed to: Stanford University Office of Technology Licensing [***] PORTIONS OF THIS EXHIBIT HAVE BEEN REDACTED PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST. AN UNREDACTED VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE COMMISSION. EXECUTION VERSION Department #44439 X.X. Xxx 00000 Xxx Xxxxxxxxx, XX 00000-0000 All progress reports to Stanford are e-mailed or mailed to: Office of Technology Licensing 0000 Xx Xxxxxx Xxxx Xxxxxxxx 0, Xxxxx 000 Xxxx Xxxx, XX 00000-0000 xxxx@xxxxxxx.xxxxxxxx.xxx [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Any notice related to Section 7.4 (Purchase Right) or Section 7.5 (Stanford Purchase Rights Agreements; Information Rights; Notice; Elections) shall be copied concurrently to xxxxxxxxxx@xxxxxxxx.xxx xxxxxxxxxx@xxxxxxxx.xxx. Either party may change its address with written notice to the other party.

All Notices. All notices under this Agreement are deemed fully given when written, addressed, and sent as follows: All general notices to Forty Seven Aditxt are mailed or emailed to: Name: Amro Xxxxxxx 00000 Xxxxxxxx XxxXxxxxx Forty Seven Inc. [*] With a copy toXxxxxx, Suite 105- Address: 00000 Xxxx Xxxxxxx Xxxxxx Xxxxxxx Xxxxxxxx & Xxxxxx 000 Xxxx Xxxx Xxxx Xxxx XxxxXxxxx, XX 00000 xxxxxxxx@xxxx.xxx Email: xxxxxxxx@xxxxxx.xxx All financial invoices to Forty Seven Aditxt (i.e., accounting contact) are e-mailed to: Xxxxxxxx XxxXxxxxx [*] Name: Accounts payable Email: xxxxxxxxxx@xxxxxx.xxx All progress report invoices to Forty Seven (i.e., technical contact) patent prosecution related notices are e-mailed toto both addresses below: Xxxxxxxx XxxXxxxxx [*] Name: Patent Notices Email: xxxxxxxxxx@xxxxxx.xxx Name: Seed IP Email: xxxxxxxxxx@XxxxXX.xxx All general notices to Stanford are e-mailed or mailed to: Office of Technology Licensing 000 Xxxxxxxx Xxxxxx 0xx Xxxxx, XX 0000 Xx Xxxxxx Xxxx Xxxxxxxx 0, Xxxxx 000 Xxxx Xxxxxxx Xxxx, XX 00000-0000 00000 xxxx@xxxxxxx.xxxxxxxx.xxx All payments to Stanford are mailed to: Stanford University Office of Technology Licensing Department #44439 X.X. Xxx 00000 Xxx Xxxxxxxxx, XX 00000-0000 All progress reports to Stanford are e-mailed or mailed to: Office of Technology Licensing 000 Xxxxxxxx Xxxxxx 0xx Xxxxx, XX 0000 Xx Xxxxxx Xxxx Xxxxxxxx 0, Xxxxx 000 Xxxx Xxxxxxx Xxxx, XX 00000-0000 00000 xxxx@xxxxxxx.xxxxxxxx.xxx [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Any notice related to Section 7.4 or Section 7.5 (Stanford Purchase Rights) shall be copied concurrently to xxxxxxxxxx@xxxxxxxx.xxx xxxxxxxxxx@xxxxxxxx.xxx. Either party may change its address with written notice to the other party.

All Notices. All notices under this Agreement are deemed fully given when written, addressed, and sent delivered (with delivery confirmed in writing) as follows: All general notices to Forty Seven Eidos are mailed or emailed to: Xxxxxxxx XxxXxxxxx Forty Seven Eidos Therapeutics, Inc. [*****] With a copy copy, which shall not constitute notice, to: Xxxx : Xxxxxxx X. Xxxxxx Xxxxxx LLP 0000 Xxxxxxx Xxxxxx Xxxxxxx Xxxxxxxx & Xxxxxx 000 Xxxx Xxxx Xxxx Xxxx Xxxx, XX 00000 xxxxxxxx@xxxx.xxx All financial invoices to Forty Seven Eidos (i.e., accounting contact) are e-mailed to: Xxxxxxxx XxxXxxxxx Xxxxxx Xxxxxxxxxxx [*****] All progress report invoices to Forty Seven Eidos (i.e., technical contact) are e-mailed to: Xxxxxxxx XxxXxxxxx Xxxxxx Xxxxxxxxxxx [*****] All general notices to Stanford are e-mailed or mailed to: Office of Technology Licensing 0000 Xx Xxxxxx Xxxx Xxxxxxxx 0, Xxxxx 000 Xxxx Xxxx, XX 00000-0000 xxxx@xxxxxxx.xxxxxxxx.xxx [*****] [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. All payments to Stanford are mailed to: Stanford University Office of Technology Licensing Department #44439 X.X. Xxx 00000 Xxx Xxxxxxxxx, XX 00000-0000 All progress reports to Stanford are e-mailed or mailed to: Office of Technology Licensing 0000 Xx Xxxxxx Xxxx Xxxxxxxx 0, Xxxxx 000 Xxxx Xxxx, XX 00000-0000 xxxx@xxxxxxx.xxxxxxxx.xxx [******] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Any notice related to Section 7.4 or Section 7.5 (Stanford Purchase Rights) shall be copied concurrently to xxxxxxxxxx@xxxxxxxx.xxx [*****] Either party may change its address with written notice to the other party.

All Notices. All notices under this Agreement are deemed fully given when written, addressed, and sent as follows: All general notices to Forty Seven Jasper are mailed or emailed to: Xxxxxxxx XxxXxxxxx Forty Seven Jasper Therapeutics, Inc. [*] With a copy to0000 Xxxxxx Xxxx, Xxxxx #000 Xxxxxxx Xxxx, Xxxxxxxxxx XX 00000 Attention: Xxxx Xxxxxxx Xxxxx Email: […***…] and Jasper Therapeutics, Inc. 0000 Xxxxxx Xxxxxxx Xxxxxxxx & Xxxxxx 000 Xxxx Xxxx Xxxx Xxxx Xxxx, Xxxxx #000 Xxxxxxx Xxxx, Xxxxxxxxxx XX 00000 xxxxxxxx@xxxx.xxx Attention: Contracts Email: […***…] All financial invoices to Forty Seven Jasper (i.e., accounting contact) are e-mailed to: Xxxxxxxx XxxXxxxxx Accounts Payable […***…] All progress report invoices to Forty Seven Jasper (i.e., technical contact) are e-mailed to: Xxxxxxxx XxxXxxxxx Xxxx Xxxxx […***…] and Contracts […***…] All general notices to Stanford are e-mailed or mailed to: Office of Technology Licensing 000 Xxxxxxxx Xxxxxx 0xx Xxxxx, XX 0000 Xx Xxxxxx Xxxx Xxxxxxxx 0, Xxxxx 000 Xxxx Xxxxxxx Xxxx, XX 00000-0000 00000 xxxx@xxxxxxx.xxxxxxxx.xxx All payments to Stanford are mailed to: Stanford University Office of Technology Licensing Department #44439 X.X. Xxx 00000 […***…] […***…] Xxx Xxxxxxxxx, XX 00000-0000 All progress reports to Stanford are e-mailed or mailed to: Office of Technology Licensing 000 Xxxxxxxx Xxxxxx 0xx Xxxxx, XX 0000 Xx Xxxxxx Xxxx Xxxxxxxx 0, Xxxxx 000 Xxxx Xxxxxxx Xxxx, XX 00000-0000 00000 xxxx@xxxxxxx.xxxxxxxx.xxx [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Any notice related to Section 7.4 7.2 or Section 7.5 7.3 (Stanford Purchase Rights) shall be copied concurrently to xxxxxxxxxx@xxxxxxxx.xxx […***…]. Either party may change its address with written notice to the other party.

All Notices. All notices under this Agreement are deemed fully given when written, addressed, and sent as follows: All general notices to Forty Seven AKOYA are mailed or emailed to: Dxxxx Xxxxxxxx XxxXxxxxx Forty Seven Inc. [*] 300 Xxxx Xxxxxx, Xxxxx 000 Xxx Xxxxxxxxx, XX 00000 dxx@xxxxxxxxxx.xxx With a copy to: Xxxx cc to (which shall not constitute notice): WSGR c/o Vxxx Xxxxxxx Xxxxxx Xxxxxxx Xxxxxxxx & Xxxxxx 000 600 Xxxx Xxxx Xxxx Xxxx Xxxx, XX 00000 xxxxxxxx@xxxx.xxx 00000-0000 Phone 600.000.0000 Fax 600.000.0000 S14-157: Execution Copy Exclusive (Equity) Agreement All financial invoices to Forty Seven AKOYA (i.e., accounting contact) are e-mailed to: Xxxxxxxx XxxXxxxxx [*] Rxx Xxxx 300 Xxxx Xxxxxx, Xxxxx 000 Xxx Xxxxxxxxx, XX 00000 rxx@xxxxxxxxxx.xxx All progress report invoices to Forty Seven AKOYA (i.e., technical contact) are e-mailed to: Dxxxx Xxxxxxxx XxxXxxxxx [*] 300 Xxxx Xxxxxx, Xxxxx 000 Xxx Xxxxxxxxx, XX 00000 dxx@xxxxxxxxxx.xxx All general notices to Stanford are e-mailed or mailed to: Office of Technology Licensing 0000 3000 Xx Xxxxxx Xxxx Xxxxxxxx 0, Xxxxx 000 Xxxx Xxxx, XX 00000-0000 xxxx@xxxxxxx.xxxxxxxx.xxx ixxx@xxxxxxx.xxxxxxxx.xxx All payments to Stanford are mailed to: Stanford University Office of Technology Licensing Department #44439 X.X. P.X. Xxx 00000 Xxx Xxxxxxxxx, XX 00000-0000 All progress reports to Stanford are e-mailed or mailed to: Office of Technology Licensing 0000 3000 Xx Xxxxxx Xxxx Xxxxxxxx 0, Xxxxx 000 Xxxx Xxxx, XX 00000-0000 xxxx@xxxxxxx.xxxxxxxx.xxx [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. ixxx@xxxxxxx.xxxxxxxx.xxx Any notice related to Section 7.4 or Section 7.5 (Stanford Purchase Rights) shall be copied concurrently to xxxxxxxxxx@xxxxxxxx.xxx pxxxxxxxxxxxxxxxxxx.xxx. Either party may change its address with written notice to the other party.. S14-157: Execution Copy Exclusive (Equity) Agreement